Legal & General Group Plc boosted its position in shares of LHC Group (NASDAQ:LHCG) by 1.2% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 25,087 shares of the health services provider’s stock after buying an additional 290 shares during the period. Legal & General Group Plc owned approximately 0.14% of LHC Group worth $1,353,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. FMR LLC boosted its stake in LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock worth $87,312,000 after buying an additional 199,849 shares during the last quarter. Norges Bank purchased a new stake in LHC Group during the fourth quarter worth approximately $7,913,000. Eagle Asset Management Inc. purchased a new stake in LHC Group during the first quarter worth approximately $6,414,000. State of Tennessee Treasury Department boosted its stake in LHC Group by 899.1% in the first quarter. State of Tennessee Treasury Department now owns 119,032 shares of the health services provider’s stock worth $6,416,000 after buying an additional 107,118 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in LHC Group by 17.7% in the first quarter. Ameriprise Financial Inc. now owns 542,738 shares of the health services provider’s stock worth $29,254,000 after buying an additional 81,554 shares during the last quarter. Hedge funds and other institutional investors own 84.95% of the company’s stock.
LHC Group (LHCG) traded up 0.70% on Friday, reaching $64.31. 97,793 shares of the company’s stock traded hands. LHC Group has a 12-month low of $32.04 and a 12-month high of $69.35. The stock has a market cap of $1.18 billion, a price-to-earnings ratio of 28.46 and a beta of 0.77. The stock has a 50 day moving average price of $63.27 and a 200 day moving average price of $57.46.
LHC Group (NASDAQ:LHCG) last posted its quarterly earnings data on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.54 by $0.09. The company had revenue of $260.20 million during the quarter, compared to analysts’ expectations of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 15.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.52 earnings per share. Analysts forecast that LHC Group will post $2.39 EPS for the current year.
Several equities research analysts recently issued reports on LHCG shares. Jefferies Group LLC raised their target price on shares of LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a report on Monday, May 15th. Zacks Investment Research cut shares of LHC Group from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Royal Bank Of Canada restated a “buy” rating and issued a $69.00 target price on shares of LHC Group in a report on Monday, May 15th. BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, Oppenheimer Holdings, Inc. restated an “outperform” rating and issued a $68.00 target price (up previously from $55.00) on shares of LHC Group in a report on Monday, May 8th. Nine investment analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of $65.75.
In other LHC Group news, Director Coliseum Capital Management, L sold 145,850 shares of the company’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $61.05, for a total transaction of $8,904,142.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction on Thursday, June 8th. The stock was sold at an average price of $64.97, for a total transaction of $206,669.57. Following the transaction, the chief operating officer now owns 114,235 shares of the company’s stock, valued at $7,421,847.95. The disclosure for this sale can be found here. Insiders have sold 546,207 shares of company stock valued at $33,813,733 over the last 90 days. 14.80% of the stock is currently owned by company insiders.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.
